DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Ideal concentration of tropicamide with hydroxyamphetamine 1% for routine pupillary dilation.

Author(s): Larkin KM, Charap A, Cheetham JK, Frank J

Affiliation(s): Southern California College of Optometry, Fullerton.

Publication date & source: 1989-09, Ann Ophthalmol., 21(9):340-4.

Publication type: Clinical Trial; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

In this double-masked clinical study, we evaluated four concentrations of tropicamide (0.05%, 0.1%, 0.25%, and 0.5%) combined with hydroxyamphetamine 1% to find the combination that gives maximal pupillary dilation and inhibition of responsiveness to light and minimal paralysis of accommodation. With all concentrations, pupil size was maximal at 60 minutes, and there was no significant difference between the groups in mean pupillary diameter. Inhibition of the pupillary responses to light and loss of accommodation were directly related to the concentration of tropicamide. Tropicamide 0.25% combined with hydroxyamphetamine 1% was considered ideal for dilation and inhibition of the light response without inhibiting accommodation for near vision.

Page last updated: 2007-10-18

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012